Results 121 to 130 of about 15,436 (169)

Multimodality imaging of transthyretin amyloid cardiomyopathy

Polish Archives of Internal Medicine
Majda, Anna Patrycja, Rostoff, Paweł, Holcman, Katarzyna, Mołek-Dziadosz, Patrycja, Nessler, Jadwiga, Gajos, Grzegorz   +5 more
openaire   +3 more sources

Transthyretin amyloid cardiomyopathy-new data regarding epidemiology, diagnosis, and treatment. [PDF]

ESC Heart Fail
Tkaczyszyn M.
europepmc   +1 more source

Vutrisiran in transthyretin amyloid cardiomyopathy: a structured review of the HELIOS-B trial and its secondary analyses. [PDF]

BMC Cardiovasc Disord
Niazai A, Zurmati BM, Shah ST, Hikmat G, Sohaib HU, Zainab HH, Faridzai MJK, Nisar MR.   +7 more
europepmc   +1 more source

SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy: A Promising Signal, but Not Yet the Final Word. [PDF]

Int J Heart Fail
Kim D.
europepmc   +1 more source

Multimodality imaging characterization of Perugini scintigraphic grades in transthyretin amyloid cardiomyopathy: a single-center experience. [PDF]

J Cardiovasc Imaging
Bucius P, Zarambaite E, Lusaite K, Streckis M, Karuzas A, Plisiene J, Sakalyte G, Lapinskas T, Vajauskas D, Jankauskas A, Ereminiene E.   +10 more
europepmc   +1 more source

Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy. [PDF]

Circ Heart Fail
Masri A, Cappelli F, Davis MK, Fontana M, Garcia-Pavia P, Gillmore JD, Hanna M, Obici L, Solomon SD, Sperry BW, Tahara N, Waddington-Cruz M, Kristen AV, Falk RH, Shah SJ, Nativi-Nicolau J, Viney NJ, Yang Q, Chen J, Tsimikas S, Maurer MS.   +20 more
europepmc   +1 more source

Fully Automated versus Human Echocardiogram Interpretation in Transthyretin Amyloid Cardiomyopathy: The SCAN-MP Study. [PDF]

J Am Soc Echocardiogr
McMenamin KJ, Teruya S, Slivnick J, Alreshq R, Ullah I, Fine D, Elzieny AA, Helmke S, Gallegos C, Miller EJ, Asch FM, Hasan S, Maurer MS, Ruberg FL.   +13 more
europepmc   +1 more source

Transthyretin amyloid cardiomyopathy: from cause to novel treatments. [PDF]

Eur Heart J
Fontana M, Aimo A, Emdin M, Porcari A, Solomon SD, Hawkins PN, Gillmore JD.   +6 more
europepmc   +1 more source

Right Atrial Function as a Novel Predictor for New-Onset Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy. [PDF]

J Am Heart Assoc
Kuyama N, Izumiya Y, Takashio S, Usuku H, Tabira A, Kondo H, Saito S, Yonezu K, Kodama N, Zaizen T, Yamasaki H, Suiko Y, Ogata M, Matsuura Y, Tsuruda T, Ishii M, Yamamoto M, Hirakawa K, Kanazawa H, Hoshiyama T, Kidoh M, Oda S, Hanatani S, Matsuzawa Y, Yamamoto E, Ueda M, Takahashi N, Kaikita K, Tsujita K.   +28 more
europepmc   +1 more source

Monitoring patients with transthyretin amyloid cardiomyopathy

Heart
openaire   +2 more sources